Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Armata Pharmaceuticals, Inc. (ARMP) had Return on Investments of -255.04% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$5.17M |
|
$-18.92M |
|
-- |
|
$5.17M |
|
$47.61M |
|
$-42.44M |
|
$23.52M |
|
$-18.92M |
|
$-18.92M |
|
$-18.92M |
|
$-18.92M |
|
$-18.92M |
|
$-18.92M |
|
$-42.44M |
|
$-41.11M |
|
36.16M |
|
59.06M |
|
$-0.52 |
|
$-0.89 |
|
| Balance Sheet Financials | |
$11.31M |
|
$13.24M |
|
$75.13M |
|
$86.44M |
|
$48.25M |
|
$55.44M |
|
$86.21M |
|
$134.46M |
|
$-48.02M |
|
$-51.51M |
|
$-48.02M |
|
36.18M |
|
| Cash Flow Statement Financials | |
$-37.55M |
|
$-1.88M |
|
$34.96M |
|
$19.24M |
|
$14.77M |
|
$-4.47M |
|
$2.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.23 |
|
-- |
|
-- |
|
7.47 |
|
-1.97 |
|
100.00% |
|
-820.18% |
|
-820.18% |
|
-794.57% |
|
-365.60% |
|
-365.60% |
|
$-39.43M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
6.95 |
|
52.49 |
|
39.39% |
|
36.72% |
|
-21.88% |
|
|
Return on Investments |
-255.04% |
$-1.33 |
|
$-0.67 |
|
$-0.64 |
|